Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest IDEXX Laboratories Stories

2014-04-15 16:27:59

WESTBROOK, Maine, April 15, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), has scheduled the release of its 2014 first quarter financial results for Friday, April 25, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call through a link on the IDEXX website, http://www.idexx.com. An archived edition of the call will be available after 1:00...

2014-03-11 16:26:47

WESTBROOK, Maine, March 11, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced the unanimous election of Daniel M. Junius as a member of the Company's Board of Directors, effective March 11, 2014. Mr. Junius fills a vacancy on the Board for a Class I director, the remaining term for which ends at the Company's 2015 annual meeting of stockholders. "I am very pleased and excited to welcome Daniel Junius to our Board of Directors," said Jonathan Ayers, the...

2014-02-25 16:30:07

WESTBROOK, Maine, Feb. 25, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), announced today that it will participate in the Raymond James 35(th) Annual Institutional Investors Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Tuesday, March 4, 2014 at 11:35 a.m. ET, at the JW Marriott Grande Lakes, Orlando, Florida. Individuals can access the live audio webcast of the presentation through...

2014-01-23 16:25:33

WESTBROOK, Maine, Jan. 23, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), has scheduled the release of its 2013 fourth quarter and full-year financial results for Tuesday, February 4, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. (Logo: http://photos.prnewswire.com/prnh/20110602/NE13041LOGO ) Individuals can access a live webcast of the conference call through a link on the IDEXX website,...

2014-01-13 08:26:35

Advanced technology expands the leading line of IDEXX point-of-care analyzers and combines a full chemistry panel with electrolytes and total T4 (thyroxine) into a single sample run to deliver unprecedented diagnostic insight WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry Analyzer. Engineered to deliver the same...

2013-12-13 08:25:03

Editor Note: For more information about this release, please scroll to bottom. New York, December 13, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Hologic Inc. (NASDAQ: HOLX), IDEXX Laboratories, Inc. (NASDAQ: IDXX), Endologix Inc. (NASDAQ: ELGX) and Healthways Inc. (NASDAQ: HWAY). Today's readers may access these reports free of charge - including full price targets, industry analysis...

2013-11-20 16:26:32

WESTBROOK, Maine, Nov. 20, 2013 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), announced today that it will participate in the Piper Jaffray 25(th) Annual Healthcare Conference. Michael Williams, PhD, Executive Vice President, will present on Tuesday, December 3 at 8:30 a.m. ET, at the New York Palace Hotel, New York, New York. A live audio webcast of the presentation will be available through a link on the homepage of the IDEXX Laboratories website, www.idexx.com. An...

2013-11-08 08:27:48

NEW YORK, November 8, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Baxter International Inc. (NYSE: BAX), Seattle Genetics Inc. (NASDAQ: SGEN), IDEXX Laboratories, Inc. (NASDAQ: IDXX), Hill-Rom Holdings, Inc. (NYSE: HRC), and BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX). Today's readers may access these reports free of charge - including full price...

2013-10-22 08:32:12

WESTBROOK, Maine, Oct. 22, 2013 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012. Organic revenue growth[1] was 7.4% in the third quarter of 2013 versus the same period of the prior year. Earnings per diluted share ("EPS") for the quarter ended September 30, 2013 increased 13% to $0.86, compared to $0.76 for the same period in the prior year....

2013-10-15 08:33:01

WESTBROOK, Maine, Oct. 15, 2013 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced the appointment of Brian McKeon to serve as the Company's Executive Vice President and Chief Financial Officer, effective January 1, 2014. As Chief Financial Officer, McKeon will be a member of the Company's senior executive leadership team and will have oversight of the finance and information technology functions. McKeon will report to Jonathan Ayers, Chairman, President and...